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All  penicillin-binding  proteins (PBPs) contain  a con- 
served box  of  homology  in  the  carboxyl-terminal  half 
of their primary sequence that can be Lys-Thr-Gly, 
Lys-Ser-Gly, or His-Thr-Gly. Site-saturation muta- 
genesis was used  to  address  the  role  of  the lysine resi- 
due at this position  (Lys2”)  in Escherichia  coli PBP 5, 
a D-alanine  carboxypeptidase  enzyme. A soluble  form 
of PBP 5 was used to replace Lys213 with 18 other 
amino  acids, and  the ability of these  mutant  proteins 
to bind [SH]penicillin G was assessed.  Only  the  substi- 
tution of lysine with arginine  resulted  in  a  protein  that 
was capable  of  forming a stable  covalent  complex with 
antibiotic.  The affinity of  [’4C]penicillin G for  the  ar- 
ginine mutant was 1.2-fold higher  than  for wild-type 
PBP 6 (4.4 versus 5.1 pg/ml  for 20 min  at 30 “C), and 
both  proteins  showed  identical rates of  hydrolysis  of 
the [’4C]penicilloyl-bound complex (tl12 = 9.1 min). 
Surprisingly, the  arginine-substituted  protein was un- 
able to catalyze  D-alanine  carboxypeptidase activity in 
vitro, which  suggests  that  there is a  substantial differ- 
ence in the geometries of the peptide substrate and 
penicillin G within  the active site of PBP 5. 
Penicillin and  other p-lactam antibiotics  exert  their  lethal 
effect by binding to and covalently inactivating the enzymes 
that are involved in  the synthesis of peptidoglycan at  the 
bacterial cell surface (1). These cell wall synthesis enzymes, 
called penicillin-binding proteins  (PBPs),’  can be detected by 
incubation of bacterial membranes with radiolabeled penicil- 
lin G,  followed by SDS-polyacrylamide gel electrophoresis 
and fluorography (2). In Escherichia coli, there  are at least 
seven proteins that can be detected in this manner, and 
biochemical and genetic analysis indicates that these PBPs 
fall  into two distinct groups. The high molecular weight PBPs 
(PBPs lA,  lB, 2, and 3) are  essential for cell viability and  are 
thought  to be bifunctional enzymes that catalyze both peni- 
cillin-insensitive transglycosylase reactions and penicillin- 
sensitive transpeptidase reactions utilizing the lipid-linked 
disaccharide pentapeptide (3-6). The low molecular weight 
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PBPs  (PBPs 4-6) catalyze either secondary transpeptidase 
activity (PBP 4) (7) or D-alanine carboxypeptidase activity 
(PBPs 4-6) (8-10). Although they make up close to 90% of 
the [14C]penicillin G binding to cell membranes, the low 
molecular weight PBPs  do  not appear to be essential for cell 
viability. 
Another group of enzymes, called p-lactamases, also inter- 
acts with penicillin and  other p-lactam antibiotics. The pro- 
duction of these enzymes is the major clinical cause of resist- 
ance to p-lactam  antibiotics (11). P-Lactamases are known to 
catalyze the hydrolysis of 8-lactam antibiotics through an 
acyl-enzyme mechanism that is very similar to  the mechanism 
of B-lactam antibiotic  interaction with PBPs. When the pri- 
mary structures of several PBPs  and p-lactamases became 
available, however, the sequence homology between the two 
groups of enzymes was found to be quite low. The greatest 
homologies are found within the region of the active-site 
serine residues. Within this small region, up  to 60% homology 
can be observed in some cases, but  it quickly decreases as 
larger and larger regions are compared. The lack of significant 
sequence homology between PBPs  and p-lactamases brought 
into question the evolutionary relatedness of these two groups 
of enzymes. The relatedness was strongly suggested, however, 
when the crystal structures of either Bacillus licheniformis 
749/C #3-lactamase (12) or Bacillus cereus p-lactamase I (13) 
were compared to  the crystal  structure of the low molecular 
weight  DD-peptidase from Streptomyces R61 (14). The simi- 
larities of the secondary structures of these enzymes were 
quite  striking, even though the two enzymes differed by 8 kDa 
and showed  very little sequence homology. 
The evolutionary relationship between these two groups of 
penicillin-interactive enzymes was further investigated using 
homology searches and amino acid alignments, using the 
Streptomyces R61 D-alanyl-D-alanine peptidase as  a reference, 
of all of the known sequences of PBPs and  8-lactamases (15). 
This method identified several regions, called boxes, that 
consist of strict  identities or homologous amino acids. These 
boxes,  whose importance  is highlighted by the known struc- 
tures of several members of the penicillin-interactive family, 
are  situated in or near the active site of these enzymes and 
catalyze the acyl-exchange reactions that occur during  turn- 
over. One of these conserved regions, called Box 11, is the 
well-characterized Ser-X-X-Lys  tetrad that contains the ac- 
tive-site serine nucleophile. Another interesting region of 
homology, called Box VII, is  a conserved triad Lys-Thr-GIy, 
Lys-Ser-Gly, or  His-Thr-Gly that occurs within the carboxyl- 
terminal half of the primary sequence of these enzymes.  Kelly 
et al. (16), from the crystallographic analysis of @-lactam 
antibiotics bound to  the Streptomyces R61 DD-peptidase,  have 
suggested that  the binding of substrate is facilitated by the 
conserved triad of Box VI1 and  that  the histidine residue 
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contributes to the initial binding.  Because these hypotheses 
have  not  been tested at the biochemical level, however, the 
role of the basic  residue  within the Box VI1  region  of PBPs 
has not  been  confirmed. 
We chose to investigate the role of the conserved lysine 
(Lys2I3) of Box VI1 in the catalytic  mechanism of E. coli PBP 
5 to gain  a  better  understanding  of the role  of this amino  acid 
in the molecular interactions of a PBP with both p-lactam 
antibiotics and peptide substrate. PBP 5 is a low molecular 
weight PBP with  a M, of 41,300 that is known to catalyze the 
major  D-alanine  carboxypeptidase activity in vivo (17, 18). It 
is initially synthesized with  a  signal  sequence that is cleaved 
off during translocation to the periplasm (19). The carboxyl- 
terminal 15 amino acids have been shown to mediate the 
association of the protein  with the membrane as removal  of 
these amino  acids results in the synthesis of a  soluble  peri- 
plasmic  protein (20).  PBP 5 is unique in that it displays the 
highest p-lactamase activity of all of the E. coli PBPs; at pH 
7 and 30 “C, the half-life of the acyl-enzyme  complex is -10 
min (21, 22). The D-alanine  carboxypeptidase activity that it 
catalyzes can also be easily assayed in vitro. We chose the 
method of site-saturation mutagenesis to investigate the role 
of the basic  residue  in the Box VI1  region  of a  soluble form  of 
PBP 5 in which  Lys213  was mutated to 18 other  amino  acids 
and the properties  of these mutants were investigated. 
EXPERIMENTAL PROCEDURES 
Materials-All restriction enzymes and DNA-modifying enzymes 
were from Pharmacia  LKB Biotechnology Inc. [“CIPenicillin G (155 
pCi/mg) was from Amersham Corp. [3H]Penicillin G (57.8 mCi/mg) 
was the generous gift of Dr. Patrick Casey (Merck Sharp  and Dohme). 
Oligonucleotides were synthesized on a Milligen/Biosearch Cyclone 
Plus DNA synthesizer. The  strains of E. coli used were JM103 with 
M13 vectors, CJ236 (dut-, ung-) for the production of uracil-contain- 
ing M13 phage, and NK5830 (F’ lacIqpro/arg Alac proxrrrNalA rif’ 
recA-56 suo ara thy) for the overexpression of cloned genes of PBP 5 
mutants. Sequencing was performed with the Sequenase I1 kit from 
United States Biochemical Corp. 
Construction of Soluble PBP 5 Expression Vector-A soluble form 
of PBP 5 (sPBP 5) was constructed as described previously (22). The 
truncated dacA gene encoding sPBP 5 was reconstructed in the 
expression vector pTTQ18 (Amersham International) by standard 
cloning techniques (23). Since pTTQ18 uses ampicillin resistance as 
its selectable marker, which is detrimental to the detection and 
purification of PBPs,  the vector was modified by digesting with DraI, 
which removes a 700-bp fragment from within the ampicillin resist- 
ance gene, and ligating the kanamycin resistance gene from pUC4K 
(digested with HindII;  Pharmacia) back in  its place. The final con- 
struct, which contains the dacA gene encoding sPBP 5, the kanamycin 
resistance gene, and  the lacF gene, was designated pWT3K.  A deriv- 
ative of pWT3K, called pKM1325, was also constructed to be a 
recipient of the mutagenized fragments generated below. In this 
derivative, the 293-bp SalI-BglII fragment within the dacA gene  was 
replaced with the 1325-bp SalI-BglII fragment from pMSG (Phar- 
macia), which allowed the unambiguous detection of reconstructed 
dacA mutants by restriction screening (see below). 
Site-saturation Mutagenesis-The 1230-bp EcoRI-Hind111 frag- 
ment from pWT3K was cloned into M13mp19, and  the recombinant 
M13 phage was used to make uracil-containing  single-stranded DNA 
as described by Kunkel (24). Site-saturation mutagenesis was per- 
formed by first using an oligonucleotide to loop-out the AAA lysine 
codon, which  was then followed by another oligonucleotide to loop- 
in random codons in the former position of the AAA codon. This 
dual procedure was employed to prevent bias for the wild-type codon 
and presented a way to identify codon insertions by hybridization 
GTC GAC  GGC ATC ACC  GGA  CAC ACT-3’, which consists of the 
(see below). The loop-out oligonucleotide synthesized was 5’- 
codons for residues 209-217 that surround the  KTG  triad of sPBP 5, 
with the exception of  Lys213. Uracil-containing  single-stranded DNA 
template was mutagenized with this loop-out oligonucleotide, and 
positive phage were identified by sequencing. Uracil-containing tem- 
plate was made from one of the positive phage and was used to 
perform loop-in oligonucleotide-directed mutagenesis. This loop-in 
oligonucleotide, 5’-GTC GAC GGC  ATC NNN AAC  CGG  ACA  CAC 
T-3’, contained all four bases in equimolar amounts  in each of the 
three positions of the former AAA codon. The resultant single- 
stranded phage were screened with 32P-labeled loop-out oligonucleo- 
tide as described previously (22), and single-stranded DNAs were 
prepared from nonhybridizing phage. Positive phage containing co- 
dons for 16 amino acids at codon  213  were  identified  by  dideoxy chain 
termination sequencing (25) using Sequenase I1 (United States Bio- 
chemical Corp.) and a 17-mer oligonucleotide (5”TAACGGCCTGT- 
TATGGG-3’) that primed 26 nucleotides upstream from the KTG 
triad. The yield of positive phage containing an inserted codon  was 
50%. 
Due to  the repeated isolation of the same amino acids with different 
codons, only 16 mutants were found by this method. This in fact 
appeared to be due to a bias of the oligonucleotide, such that  the ratio 
of G at each position was much lower than expected. For the remain- 
ing three mutants, specific loop-in oligonucleotides were synthesized 
using the same sequence as above, except that codons specifying for 
glycine (GGT), glutamic acid (GAG), and tryptophan (TGG) were 
used in place of the former AAA codon. Mutagenesis was repeated as 
described above, and  the final three mutations were obtained. In cases 
where degenerate codons were isolated, the mutations containing the 
most highly used codon based on the codon preference from E. coli 
as shown by Sharp  and Li (26) were selected. The single-stranded 
DNA from each selected mutant was sequenced through the  SalI- 
BglII fragment to ensure that no other  mutation had occurred during 
mutagenesis. The replicative forms of each mutation were prepared, 
and  the 293-bp SalI-BglII fragment was isolated and used to replace 
the exogenous 1325-bp SalI-BglII fragment from pKM1325 (con- 
structed as described above). 
Expression of sPBP 5 Mutants-Cells harboring the  sPBP 5 mu- 
tant genes in pKM3K were grown at 37 “C in 50 ml of 2 X YT 
medium (23) in the presence of 50 pg/ml kanamycin. When the 
absorbance at  600 nm reached 0.5, protein  synthesis was induced by 
adding isopropyl-1-thio-P-D-galactopyranoside to a  final  concentra- 
tion of 0.5 mM and incubating with shaking for an additional 2 h. 
The cultures were subjected to osmotic shock as described by Kustu 
and Ames (27), and  the sterile shock fluids were concentrated 10-fold 
on an Amicon ultrafiltration device fitted with a PM-10 filter. The 
final protein concentrations of shock fluids were  2-5 mg/ml as 
estimated by the protein assay of Lowry et al. (28). 
PHIPenicillin G Binding and Immunoblotting of sPBP 5 Mutants- 
Aliquots of each shock fluid (20 pg)  were incubated with [3H]penicillin 
G at  a final concentration of 40 pg/ml for 20 min at 30 “C, and  the 
labeled proteins were visualized by SDS-PAGE and fluorography. 
The gel  was treated with EN3HANCE (Du Pont-New England Nu- 
clear), dried, and exposed to Kodak XAR-5 film. The  mutant  sPBP 
5-K213Y (sPBP 5  containing  a Lys to Tyr  mutation at position 213) 
was not analyzed for binding activity due to  its loss during cloning 
and was not pursued. To determine that absence of binding was not 
due to  the absence of the protein  in the shock fluid, the amount of 
expression of each mutant was assessed by immunoblotting. Aliquots 
(20 pg)  of osmotic shock fluids were separated on a 12% SDS- 
polyacrylamide gel and transferred to nitrocellulose using a semidry 
blotting  apparatus. After blocking with nonfat dry milk, the nitrocel- 
lulose  was incubated first with antiserum raised against sPBP 5’ and 
then with alkaline phosphatase-conjugated goat anti-rabbit Fab frag- 
ment (Sigma). The  sPBP 5  proteins were visualized with 5-bromo-4- 
chloro-3-indolyl phosphate and nitro blue tetrazolium (29). The  anti- 
serum was produced by injecting an SDS-polyacrylamide gel suspen- 
sion of sPBP  5’ subcutaneously into New Zealand white rabbits as 
described by Harlow and Lane  (30). 
Determination of Affinities of sPBP 5 and  sPBP 5-K213R for p4C] 
Penicillin G-The affinities of sPBP 5 and  sPBP 5-K213R for [“C] 
penicillin G were measured essentially as described by Ghuysen et al. 
(31). Aliquots (15 pl) of either the purifiedproteins (1.5 pg) or osmotic 
shock fluids (20 pg) were incubated with 5 p1 of serial dilutions of 
[‘4C]penicillin G (80-1.25 pg/ml final concentration) for 20 min at 
30 “C. Following incubation, SDS-PAGE sample buffer was added, 
and  the samples were separated  on  a 12% SDS-polyacrylamide gel. 
The gel was treated with EN3HANCE, dried, and exposed to film. 
The amount of radioactivity present  in the proteins was estimated by 
densitometric scanning of the film with a Hoefer Scientific Instru- 
ments GS 300 densitometer. 
Determination of Rate of Hydrolysis of Bound p‘C]Penicillin G by 
sPBP 5 and sPBP 5-K213R”Hydrolysis assays were performed 
essentially as described previously (22). Aliquots of purified proteins 
(6 pg, 1 pgltime  point) or osmotic shock fluids (120 pg, 20 pgltime 
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point) in 25 mM Tris. HCl, pH 7.3, were incubated with ["Clpenicillin 
G at  a final concentration of 40 pg/ml at 30 'C. After 20 min, 
nonradioactive penicillin G was added to a  final  concentration of 4 
mg/ml, and  the incubation was continued. Aliquots were  removed at 
various times, and  the amount of radioactivity remaining in  the  sPBP 
5 proteins was determined by SDS-polyacrylamide gel electrophore- 
sis, fluorography, and densitometry as described above. 
D-Alanine Carboxypeptidase Assays-D-Alanine carboxypeptidase 
activity was measured exactly as described previously (22) using the 
pentapeptide L-Ala-D-r-Glu-L-Lys-D-Ala-D-Ala ( % F a ) .  The 
amount of D-alanine released after 30 min in 50 mM Trls.HC1, pH 
8.5, was determined by the spectrophotometric assay utilizing D- 
amino-acid oxidase as described by Fr6re et al. (32). The kinetic 
parameters VmaX and K,,, were determined from Lineweaver-Burk 
plots of two independent experiments. 
RESULTS 
Box VII Sequences of PBPs  and Site-saturation Mutagen- 
esis-Alignment of the sequences of E. coli PBPs,  the  Strep- 
tomyces R61 DD-peptidase, and several p-lactamases in  the 
region of Box VI1 shows the conserved character of the  triad 
(Fig. 1). This  triad  can  in  fact be KTG, KSG, or  HTG. We 
chose to investigate the apparent role of the lysine residue 
(Lys2I3) of the Box VI1 region in  the catalytic mechanism of 
sPBP 5 .  A soluble form of PBP 5 was chosen for mutational 
analysis since it can  be  separated from endogenous PBP 5 by 
osmotic shock, and  it is known that removal of the carboxyl- 
terminal membrane anchor of PBP 5 does not effect its 
activity (22). The entire sPBP 5 coding sequence was cloned 
into M13mp19 to generate a  template for mutagenesis. Site- 
saturation mutagenesis was performed as described under 
"Experimental Procedures," and mutant genes containing 
random codon insertions specifying all 20 amino acids at  the 
former position of  Lys213 were identified by sequencing. 
Subcloning of sPBP 5 Mutants into Expression Vector-For 
the subcloning of sPBP 5 mutant genes into an expression 
vector, we employed a strategy that allowed us to clone a 
small fragment of the  PBP 5 mutant gene into an altered 
plasmid that recreated the  entire gene including the mutation. 
The expression vector pKM1325 contained the wild-type 
sPBP 5 gene, except that  the 293-bp Sun-BglII  fragment that 
encompasses the Box VI1 region  (Fig.  2)  was replaced with a 
1325-bp SaZI-BgZII fragment from an unrelated plasmid 
(pMSG). This strategy allowed us to subclone a small se- 
quenced fragment from the mutagenesis (all 20 mutants were 
sequenced through the SalI-BgZII fragment to ensure that 
SnLYba - ,KanIQN- 
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FIG. 1. Box VI1 sequences of selected PBPs and 8-lacta- 
mwes. The sequences encompassing the Box VI1 region of PBPs 
and p-lactamases are compared with one another; and the KTG, 
KSG, or HTG conserved triad is boxed. The positions of the sequences 
in  the primary structure of each enzyme are noted, and  the lysine 
residue that was selected for mutation in PBP 5 is indicated in 
boldface  type. 
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FIG. 2. Expression vector for overproduction of sPBP 6 
mutants. pKM3K is a derivative of pTTQ18  in which the ampicillin 
resistance gene was replaced with the kanamycin resistance gene and 
the sPBP 5 gene was cloned into the EcoRI-Hind111 sites of the 
polylinker. The DNA encoding sPBP 5 is shown expanded above the 
map along with a schematic of the protein sequence. The protein is 
initially translated with a signal sequence that is removed during its 
translocation to  the periplasmic space. The last 15 amino acids of 
PBP 5 have been deleted, which results  in the production of a soluble 
enzyme. The Box VI1 triad is indicated by X x x  Thr Gly, where X x x  
refers to  the site-saturation position that was substituted with 18 
other  amino acids. Serine 44 is the active-site nucleophile that forms 
the covalent bond with piactam antibiotics. Kb, kilobase pairs; a a ,  
amino acids. 
only the intended  mutation was present)  without he problem 
of contamination of the original fragment. The final con- 
structs  are shown in Fig. 2. Nineteen of these plasmids (the 
tyrosine mutant was lost during the subcloning process and 
was not pursued) were transformed into NK5830, and the 
overproduction of sPBP 5 mutants in the periplasm was 
induced with 0.5 mM isopropyl-1-thio-/I-D-galactopyranoside. 
Expression and Activity of sPBP 5 Mutants-Following the 
induction of the  sPBP 5 variants, the periplasmic fraction 
was isolated from each  culture using osmotic shock and was 
used to assess both  the activities and the levels of expression 
of each mutant. To assess the [3H]penicillin G binding ac- 
tivities of the sPBP 5 variants, osmotic shock fluids were 
preincubated with [3H]penicillin G for 10 min at 30 "C and 
analyzed by SDS-PAGE and fluorography. [3H]Penicillin G 
was chosen for this experiment since its 50-fold higher specific 
activity compared with ['4C]penicillin G should have allowed 
us  to observe even low level binding. As shown in Fig. 3A, 
however, only the Arg mutant  and  the  "revertant" wild-type 
sPBP 5 proteins were detected under these conditions. To 
test whether adequate levels of sPBP 5 mutant  proteins were 
present  in the samples that did not show binding, immunoblot 
analysis was performed on each sample (Fig. 3B).  The im- 
munoblot revealed that 18 (out of 19 total) variants were 
stable and expressed at levels equal to or exceeding those of 
sPBP 5. To ensure that  the gene encoding sPBP 5-K213R 
had  not reverted back to  the wild-type sequence, the plasmid 
was isolated and submitted to double-stranded sequencing, 
which confirmed the presence of an arginine codon (CGT) at 
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FIG. 3. Analysis of sPBP 5 mutants by [3H]penicillin G bind- 
ing and immunoblotting. A, osmotic shock fluids (20 pg) were 
incubated with ['Hlpenicillin G a t  a  final concentration of 40 pg/ml 
for 20 min at  30 "C, following which the samples were denatured  in 
SDS  and subjected to electrophoresis on a 12% SDS-polyacrylamide 
gel. The bands were visualized by fluorography. The amino acid 
substitution at  position 213 is  indicated above each lane. B, osmotic 
shock fluids (20 pg) were subjected to electrophoresis as described 
above and transferred to nitrocellulose, and  the bands were visualized 
by immunoblotting  with antisera  against sPBP 5'. In  both cases, only 
the relevant part of the fluororgraph or immunoblot  is shown. 
0 
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FIG. 4. Affinity of sPBP 5 and sPBP 5-K213R for ["C] 
penicillin G. Aliquots of purified sPBP 5 or  sPBP 5-K213R were 
incubated for 20 min a t  30 "C with  increasing concentrations of  ["C] 
penicillin G. Following this incubation, the samples were submitted 
t o  SDS-polyacrylamide gel electrophoresis  on  a 12%  gel and fluoro- 
graphed. The  amount of radioactivity bound was determined by a 
densitometric scan of the bands following fluorography, and the 
percent of ["Clpenicillin G  bound at  each concentration (calculated 
from the value a t  80 pg/ml) was graphed on a semilog plot uersus 
the concentration of [14C]penicillin G. The concentration of ["C] 
penicillin G that results in 50% binding for each protein  is indicated 
(- - -). 
position 213. On the basis of this binding activity, we selected 
sPBP 5-K213R to  further characterize its catalytic activity. 
Activities of sPBP 5-K213R"To determine whether any 
subtle effects had occurred within the active site  in  sPBP 5- 
K213R, the affinities of sPBP 5 and  sPBP 5-K213R for ["C] 
penicillin G were determined. Because of the  nature of the 
reaction of penicillin G  with PBPs,  it should  be  noted that 
the term  affinity is defined as  the concentration of antibiotic 
that results  in the covalent labeling of 50% of the particular 
PBP under defined conditions (in  this case, 20 min a t  30 "C; 
see Ref. 31 for further details). The  saturation curves shown 
in Fig. 4 were obtained after incubating the  sPBP 5 proteins 
with [14C]penicillin G at  various concentrations for 20 min a t  
30 "C. From these  data, it was determined that  sPBP 5-K213R 
(affinity = 4.4 pg/ml) has a 1.2-fold higher affinity for ["C] 
penicillin G compared with sPBP 5  (affinity = 5.2 pg/ml). 
The effect of the arginine  mutation  on the interactions of 
sPBP 5 with penicillin G was further assessed by determining 
the  rate of deacylation of the [14C]penicilloyl-sPBP complex. 
The purified protein was incubated with a saturating amount 
of [14C]penicillin G for 20 min at  30 "C. A 100-fold excess of 
nonradioactive penicillin G was added at  t = 0, and at  various 
times, aliquots of the proteins were removed, denatured in 
SDS, and subjected to SDS-PAGE and fluorography. The 
amount of radioactivity remaining covalently attached to 
protein was measured by densitometry. The first-order rate 
constants  and half-lives for the enzymatically catalyzed hy- 
drolysis of penicillin were calculated from a semilog plot of 
percent  activity  remaining uersus time of incubation (Fig. 5 
and  Table I). The identical half-lives of the penicilloyl-sPBP 
complexes for both sPBP 5 (tIl2 = 9.2 min) and sPBP 5- 
K213R (t112 = 9.1 min) clearly indicate that the arginine 
mutation  has no effect upon the  rate of hydrolysis of the acyl- 
enzyme complex. As a comparison, the hydrolysis rate of 
sPBP 5' is also shown. sPBP 5' contains  a  point  mutation 
(G105D) that results in a drastically reduced deacylation rate 
of the penicilloyl-sPBP 5' complex  while still allowing near- 
normal  acylation  with penicillin G (33, 34). As reported pre- 
viously (22), the half-life of the penicilloyl-sPBP 5' complex 
D 
mill 
FIG. 5. Quantitation of rate of hydrolysis of  [''C]penicillin 
G by sPBP 5, sPBP 5', and sPBP 5-K213R. Purified sPBP 5 
proteins (6 pg) were incubated with 40 pg/ml ["C]penicillin G in 25 
mM Tris.HC1, pH 7.3, for 20 min a t  30 "C. A 100-fold excess of 
nonradioactive penicillin G was then added ( t  = 0); and aliquots were 
removed at   the indicated  times,  denatured, and submitted to electro- 
phoresis  on  a 12% SDS-polyacrylamide gel. Following fluorography, 
the radioactivity  remaining covalently attached  to protein was deter- 
mined by densitometric  scanning. 
TABLE I 
Kinetic constants of wild-type and  mutant proteins 
I ~ w  for affn- Hydrolysis of Carboxypeptidase 
activity' 
penicillin G" t,h k8 K, Vm*X 
sPBP ity of [,del ["C]penicillin Gb 
pg/ml min s-l mM pmollrninlmg 
sPBP 5 5.1 9.2 0.00125 7.982 0.45 1.41 f 0.18 
sPBP 5'-G105D 14 244 4.7 X ND ND 
sPBP 5-K213R 4.4 9.1  0.00126 NDd ND 
Values were calculated from the  data in Fig. 4. 
*Values were calculated from the  data in Fig.  5. 
'Values were determined from double-reciprocal plots of initial 
rates. 
ND, not detected. 
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was extremely long (244 min) when compared with that of 
sPBP 5-K213R or sPBP 5 (9 min). The half-life determined 
for sPBP 5 differed slightly from the value determined pre- 
viously (10.5 min)  and may be a  result of the higher pH (7.3 
versus 7.0) used in  these experiments. 
Because sPBP 5-K213R showed essentially no difference 
in  its interaction with penicillin G,  we reasoned that  it would 
also catalyze D-alanine carboxypeptidase activity. To conduct 
D-alanine carboxypeptidase assays, it was necessary to purify 
both sPBP 5 and sPBP 5-K213R to homogeneity in large 
yields. Utilizing covalent ampicillin affinity chromatography, 
sPBP 5 (1.0 mg) and sPBP 5-K213R (2.6 mg)  were purified 
from osmotic shock fluids and were used to assess D-alanine 
carboxypeptidase activity (22). The kinetic parameters of the 
release of D-alanine were determined from the purified pro- 
teins  and  the  substrate L-Ala-D-r-Glu-L-Lys-D-Ala-D-Ala 
(Table I). Surprisingly, whereas sPBP 5 displayed D-alanine 
carboxypeptidase activity, no activity could be detected with 
sPBP 5-K213R. The purified protein was reassayed for peni- 
cillin binding at the same time to determine whether the 
protein had lost its binding activity, but  it showed the iden- 
tical activities that were determined in osmotic shock fluid. 
A competition experiment in which L-Ala-D-y-Glu-L-Lys-D- 
Ala-D-Ala  was preincubated at  pH 8.5 with sPBP 5-K213R 
for various times before the addition of [14C]penicillin G 
showed that  sPBP 5-K213R did not  appear to accumulate an 
acyl-enzyme complex (data  not shown). Our sPBP 5 showed 
a reproducibly higher K, (8.0 f 0.5 mM) than  the  sPBP 5 
(5.0 f 0.8 mM) reported previously (22), but  it  is not clear 
why these values are different from one another. 
DISCUSSION 
The proposed role of the histidine residue from the Box VI1 
region in the catalytic mechanism of the Streptomyces R61 
DD-peptidase was based upon the molecular coordinates of 
the histidine residue within the active-site cavity determined 
from the high-resolution crystal  structure. The histidine side 
chain appears to be in position to contribute to  the initial 
binding of substrate  and  p-lactam antibiotics, presumably by 
providing a positive charge that can  interact with the carbox- 
ylate moiety of these ligands (16). We  were interested  in this 
hypothesis and sought to confirm the role of this  amino acid 
in another low molecular weight PBP  (PBP 5). The role of 
Lys213 from the Box VI1 region of PBP 5 in the catalytic 
mechanism of this D-alanine carboxypeptidase enzyme was 
assessed by the technique of site-saturation mutagenesis. We 
reasoned that if the protonated  amino group on Lys is re- 
sponsible only for forming an electrostatic  interaction with 
the penicillin carboxylate, then one might expect that either 
arginine  or histidine could substitute for lysine in  the active 
site of sPBP 5. If L y P 3  directly participates  in the acid-base 
reactions that occur during the acylation and deacylation of 
penicillin G with PBP 5 (as might the histidine residue), then 
only the protein with a histidine at this position should be 
able to bind [3H]penicillin G. Finally, if  Lys213 is not  important 
in the binding of penicillin G, then at least some of the 
mutations should show significant binding activity. 
Using site-saturation mutagenesis, we substituted lysine 
213 of the Box VI1 region of sPBP 5 with 18 other amino 
acids and  tested the ability of these mutant proteins to bind 
[3H]penicillin G. Only one of these  proteins (sPBP 5-K213R) 
was capable of forming a  stable covalent complex with peni- 
cillin. It is very illuminating that only arginine was capable 
of substituting for lysine at  this position; since the high pK, 
of the guanidinium group of arginine makes it unsuitable for 
participating  in acid-base catalysis, the results strongly sug- 
gest that  it  is imply the positive charge contributed by these 
2 residues that is required for penicillin binding. The inability 
of histidine to substitute for lysine was unexpected since 
histidine is found at  the same position in  the Box VI1 region 
of Streptomyces R61 DD-peptidase. Since histidine is capable 
of contributing its positive charge in  the Streptomyces en- 
zyme, there  are  apparently  other  subtle conformational dif- 
ferences within the active site of sPBP 5 that prevent the 
productive interaction of the histidinium ion with the peni- 
cillin carboxylate moiety. 
The activity of sPBP 5-K213R was further investigated, 
and the mutant was found to exhibit wild-type values of 
binding affinity and hydrolysis of [l*C]penicillin G. The equiv- 
alence of both of these properties in sPBP 5 and  sPBP 5- 
K213R suggests that the arginine residue has virtually no 
effect on the structure of the active-site cavity in respect to 
penicillin binding. Interestingly, when D-alanine carboxypep- 
tidase activity was assayed, sPBP 5-K213R consistently 
showed no activity, even though its  interaction with penicillin 
was normal. This suggests that  the arginine residue, although 
situated  in  a suitable geometry for interacting with penicillin, 
is unable to form a productive electrostatic  interaction with 
the substrate carboxylate. This in part may be due to a 
different positioning of the  substrate carboxylate in  the active 
site as compared with the penicillin carboxylate, which is 
supported by modeling studies of L-lysyl-D-Ala-D-Ala and 
cephalosporin C in the active-site cavity of the Streptomyces 
R61 DD-peptidase (16). Another reason for the loss of D- 
alanine carboxypeptidase activity in sPBP 5-K213R may  be 
the different geometry of the arginine side chain  as compared 
with the lysine side chain. This difference includes both  a 1- 
A increase in the length of the arginine side chain  as compared 
with the lysine side chain and the planar geometry of the 
guanidinium moiety. These  structural differences may influ- 
ence the binding of substrate such that arginine is not capable 
of interacting with the substrate carboxylate. Although we 
cannot be sure of the structural perturbations that have 
occurred in the active site when Lys213 is replaced by  Arg, it 
does appear that  the positioning of the substrate carboxylate 
in the initial Michaelis complex is different from the penicillin 
carboxylate and  that  the arginine residue is capable of dis- 
criminating between the two compounds. 
Other  reports have detailed experiments aimed at  the role 
of lysine in  the Box VI1 region of 8-lactamases. The role of 
Lys234 (from the KTG  triad)  in  the  catalytic mechanism of B. 
licheniformis 6-lactamase was addressed by site-directed mu- 
tagenesis, in which it was mutated to either an alanine or 
glutamate residue (35). These changes resulted in  alterations 
(by 1-3 orders of magnitude) of both K, and kcat, and  this led 
to  the conclusion that Lys234 is involved in  both ground-state 
and transition-state binding. The primary sequence of the 
class C p-lactamase PSE-4 has been recently shown to exhibit 
a notable variation in the conserved triad,  in which the Lys 
residue is replaced with Arg (36). This was the first report of 
any  native penicillin-interactive protein that contains Arg at 
this position and  supports the view that  this residue provides 
a positively charged electrostatic  environment for the binding 
of the  substrate carboxylate. Recently, a  report appeared in 
which Lys234 from the KSG triad of TEM p-lactamase was 
mutated to  an arginine residue (37). The arginine-substituted 
@-lactamase displayed near wild-type levels of activity with 
cephalosporins, but showed a 10-fold decrease in K, with no 
effect on kcat for several penicillins, including penicillin G. 
These  results also suggest that arginine is capable of replacing 
lysine in the KSG triad  and  maintaining  near normal activity 
(at least for some substrates). Our results indicate that  the 
Site-saturation  Mutagenesis 
mutation of Lys213 to Arg in sPBP 5 does not affect any of 
the parameters of penicillin G binding. 
In contrast to  its interaction with penicillin G, sPBP 5- 
K213R does not catalyze any detectable D-alanine carboxy- 
peptidase activity. We do not know which of the  three param- 
eters in the kinetic scheme of D-alanine carboxypeptidation 
(binding, acylation, or deacylation) were altered  in sPBP 5- 
K213R. Of these  three, we favor the alteration of the binding 
affinity  and/or acylation rate  as  the  parameter(s) most likely 
altered in the mutant. We base this choice on two factors: 1) 
the deacylation rate displayed by sPBP 5-K213R for ["C] 
penicillin G is  identical to wild-type values, which indicates 
that  the functioning of the catalytic groups responsible for 
deacylation are not altered; and 2) no accumulation of an 
acyl-enzyme complex with the peptide substrate could be 
observed. The explanation  behind the lack of D-alanine car- 
boxypeptidase activity in sPBP 5-K213R is therefore likely 
to be fundamentally different from that  in sPBP 5', which 
also lacks D-alanine carboxypeptidase activity yet binds  pen- 
icillin. sPBP 5' lacks penicillin deacylation activity, and  its 
ability to accumulate the acyl-enzyme complex with the dep- 
sipeptide substrate (Ac)2-L-Lys-D-Ala-D-lactate can also be 
correlated with an alteration in k3 (deacylation rate  constant) 
(34). Thus, sPBP 5' has an altered  but  near-normal acylation 
rate with both  substrate  and penicillin G, but is unable to 
hydrolyze the acyl-enzyme complex. sPBP 5-K213R shows 
no such defect in the  rate of hydrolysis of penicillin G. 
It is clear that we shall  not  truly  understand the  structural 
changes that have occurred in  the mutation of Lys-213 to Arg 
until the crystal structure of sPBP 5 has been elucidated. 
Work on solving the three-dimensional  structure of sPBP 5' 
is  in progress'; and once this work comes to fruition, it will 
be very informative to determine what structural  perturba- 
tions have occurred within the active site of sPBP 5-K213R. 
We have shown that  this  mutant can be isolated in high yield 
and purity, and  it should be well suited for growing crystals. 
Comparison of the crystal  structures of sPBP 5, sPBP 5', and 
sPBP 5-K213R should allow us to  further define the roles of 
the active-site residues that participate in binding, acylation, 
and deacylation of substrate  and penicillin. 
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